BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+1.77%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.1B
AUM Growth
+$7.1B
Cap. Flow
-$139M
Cap. Flow %
-1.96%
Top 10 Hldgs %
75.68%
Holding
101
New
15
Increased
16
Reduced
17
Closed
6

Top Buys

1
BMRN icon
BioMarin Pharmaceuticals
BMRN
$81.5M
2
SGEN
Seagen Inc. Common Stock
SGEN
$56.4M
3
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
$27.2M
4
DYAX
DYAX CORPORATION
DYAX
$15.3M
5
CLVS
Clovis Oncology, Inc.
CLVS
$13.8M

Top Sells

1
VPHM
VIROPHARMA INC
VPHM
$220M
2
GILD icon
Gilead Sciences
GILD
$51.8M
3
PCYC
PHARMACYCLICS INC
PCYC
$30.8M
4
ARIA
Ariad Pharmaceuticals Inc
ARIA
$24.5M
5
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
$22.7M

Sector Composition

1 Healthcare 44.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
$922M 13% 8,719,218 -290,993 -3% -$30.8M
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
$827M 11.66% 20,735,926 +1,412,979 +7% +$56.4M
INCY icon
3
Incyte
INCY
$16.5B
$750M 10.57% 14,810,559 – –
GEVA
4
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$665M 9.37% 10,273,182 – –
ACAD icon
5
Acadia Pharmaceuticals
ACAD
$4.38B
$499M 7.03% 19,955,126 – –
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
$400M 5.63% 13,650,835 – –
XOMA icon
7
Xoma
XOMA
$392M
$155M 2.18% 23,032,372 – –
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$11.2B
$137M 1.92% 1,941,304 +1,157,993 +148% +$81.5M
HALO icon
9
Halozyme
HALO
$8.56B
$94.4M 1.33% 6,297,026 -720,582 -10% -$10.8M
VNDA icon
10
Vanda Pharmaceuticals
VNDA
$279M
$59.5M 0.84% 4,791,179 – –
CERS icon
11
Cerus
CERS
$251M
$54.5M 0.77% 8,455,306 – –
BCRX icon
12
BioCryst Pharmaceuticals
BCRX
$1.74B
$50.9M 0.72% 6,699,979 – –
RPRX
13
DELISTED
Repros Therapeutics Inc.
RPRX
$50.8M 0.72% 2,778,654 – –
QCOR
14
DELISTED
QUESTCOR PHARMA INC
QCOR
$42.2M 0.6% 775,864 +230,018 +42% +$12.5M
ANAC
15
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$42M 0.59% 2,500,000 +1,623,537 +185% +$27.2M
GILD icon
16
Gilead Sciences
GILD
$140B
$41.8M 0.59% 556,108 -689,692 -55% -$51.8M
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$39.6M 0.56% 2,380,074 +400,000 +20% +$6.65M
AEGR
18
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
$35.5M 0.5% 500,000 -320,275 -39% -$22.7M
ARWR icon
19
Arrowhead Research
ARWR
$3.05B
$33.5M 0.47% 3,090,000 -50,000 -2% -$543K
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
$32M 0.45% 530,738 +228,994 +76% +$13.8M
DSCI
21
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$27.7M 0.39% 2,558,857 – –
CHTP
22
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
$25.7M 0.36% 5,794,753 – –
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
$25.4M 0.36% 398,331 – –
ICPT
24
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$24.8M 0.35% 362,847 – –
PGNX
25
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$22.4M 0.32% 4,200,000 – –
1
2 3 4